Elevated serum CHI3L1 levels correlate with disease severity in a variety of human tumors, including breast, colon, prostate, ovarian, brain, thyroid, lung, and liver cancers, leading to poorer prognosis and shorter survival (48). The gene discussed is CHI3L1; the disease is liver cancer.